Ignite Creation Date:
2025-12-24 @ 12:08 PM
Ignite Modification Date:
2025-12-24 @ 12:08 PM
Study NCT ID:
NCT01890161
Status:
COMPLETED
Last Update Posted:
2016-02-05
First Post:
2013-06-26
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
Sponsor:
Axikin Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-26
First Submit QC Date:
None
Study First Post Date:
2013-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-02-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-01-08
Last Update Post Date:
2016-02-05
Last Update Post Date Type:
ESTIMATED